Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Cohen Fred E, Director. Officer active across 7 companies, notably CareDx, Inc.. In total, 29 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €1.2m. History available since 16 June 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cohen Fred E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Cohen Fred E is Administrateur at CareDx, Inc., Intellia Therapeutics, Inc., Progyny, Inc., FIVE PRIME THERAPEUTICS INC, Kyverna Therapeutics, Inc. and UroGen Pharma Ltd. He has 29 filings in total, and across the sampled recent filings the most frequent transaction nature is Attribution, with EUR 1,198,240 of purchases and EUR 0 of sales between 2016-01-05 and 2026-06-16.